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Abstract
Adiponectin is an adipokine secreted by white adipocytes involved in regulating insulin sensitivity in peripheral
tissues. Secretion of adiponectin in adipocytes relies on the endosomal system, however, the intracellular machinery
involved in mediating adiponectin release is unknown. We have previously reported that intracellular adiponectin
partially compartmentalizes with rab 5 and rab11, markers for the early/sorting and recycling compartments
respectively. Here we have examined the role of several rab11 downstream effector proteins (rab11 FIPs) in
regulating adiponectin trafficking and secretion. Overexpression of wild type rab11 FIP1, FIP3 and FIP5 decreased
the amount of secreted adiponectin expressed in HEK293 cells, whereas overexpression of rab11 FIP2 or FIP4 had
no effect. Furthermore shRNA-mediated depletion of FIP1 enhanced adiponectin release whereas knock down of
FIP5 decreased adiponectin secretion. Knock down of FIP3 had no effect. In 3T3L1 adipocytes, endogenous FIP1
co-distributed intracellularly with endogenous adiponectin and FIP1 depletion enhanced adiponectin release without
altering insulin-mediated trafficking of the glucose transporter Glut4. While adiponectin receptors internalized with
transferrin receptors, there were no differences in transferrin receptor recycling between wild type and FIP1 depleted
adipocytes. Consistent with its inhibitory role, FIP1 expression was decreased during adipocyte differentiation, by
treatment with thiazolidinediones, and with increased BMI in humans. In contrast, FIP1 expression increased upon
exposure of adipocytes to TNFα. In all, our findings identify FIP1 as a novel protein involved in the regulation of
adiponectin trafficking and release.
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Introduction
Adipose tissue has now been recognized as an endocrine
organ, producing and releasing a number of hormones termed
adipokines that regulate metabolism and energy homeostasis.
Adiponectin is one such adipokine secreted exclusively by
adipocytes [1–3], that functions in vivo as an insulin sensitizer
[4–6], reducing glucose production by the liver [7] and
enhancing fatty acid oxidation in skeletal muscle [6].
Adiponectin synthesis and secretion is compromised in obesity
and diabetes, resulting in decreased circulating serum levels
[8,9].
In eukaryotic cells, intracellular vesicle traffic and secretion
are complex multi-step processes that are regulated by a
diverse number of proteins in different pathways. Secretory
cargo destined for exocytosis may traffic either directly from the
trans-Golgi network to the plasma membrane (the ‘constitutive’
pathway), can be packaged to a storage compartment
(‘regulatory compartment’) or can involve the endosomal
compartment of the cell [10–13]. Studies in a range of cell
types and with a variety of secretory cargo have suggested that
the route to the cell surface can vary, depending on both the
cargo and the cell type. Despite the important role that
adiponectin plays in regulating metabolism, the mechanisms
that regulate its production, trafficking and secretion are still
poorly understood.
Adiponectin is initially synthesized in the lumen of the
endoplasmic reticulum (ER) following the removal of a short
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signal peptide. The protein moves through the Golgi and trans-
Golgi network where an important pool of adiponectin is
packaged into GGA1 (Golgi localizing γ-adaptin ear homology
domain ADP ribosylating factor -ARF- binding) coated vesicles
[14] and delivered to endosomes [14]. Other adipokines such
as adipsin also rely on the endosomal compartment for their
release (Clarke et al 2006; Millar et al. 2000), whereas leptin
does not (Xie et al 2008). Adiponectin was found to colocalize
with rab11, a marker of the Endosomal Recycling
Compartment (ERC) [15,16]. The rab11 subfamily of rab
GTPases comprises rab11a, rab11b and rab25, which localize
to the ERC and regulate endosomal trafficking through this
compartment. Currently several rab11-effector proteins have
been identified [17]. Among them, the rab11-Family of
Interacting Proteins (FIPs) comprise five members: FIP1, FIP2,
FIP3 (or Arfophilin), FIP4 (or Arfophilin-2) and FIP5 (also
known as Rip11, Gaf-1/Gaf1-b) [18,19]. Despite sharing limited
homology, all FIP proteins contain a conserved 20 amino acid
rab binding domain (RBD) which allows interaction with rab11.
FIPs have been involved in regulating multiple distinct
membrane trafficking events in several cell types. For example,
FIP2 has a role in regulating the traffic of Aquaporin 2 (AQP2)
and the chemokine receptor CXCRS2 [20,21]. In adipocytes,
FIP5 has been involved in the translocation of the facilitative
glucose transporter Glut4 containing vesicles to the cell surface
in response to insulin [22].
In order to better understand the mechanisms that regulate
adiponectin trafficking and secretion, we have examined the
role of FIPs in this process. Here we have identified rab11 FIP1
as a regulator of adiponectin secretion. We report that
overexpression of FIP1 reduces adiponectin secretion whereas
FIP1 knock down increases adiponectin release. We also show
that FIP1 expression is downregulated during adipogenesis
and by treatment with thiazolidinediones, and is inversely
correlated with BMI in humans. These findings identify FIP1 as
a new player involved in the intracellular trafficking of
adiponectin.
Materials and Methods
2.1: Materials and plasmids
HEK293 and 3T3L1 cells were obtained from ATCC.
Tissue culture reagents (FBS, trypsin, penicillin), insulin,
IBMX, dexamethasone, puromycin were from Sigma.
Adiponectin ELISA kits were from R&D (Minneapolis,
Minnesota). The following constructs were used in this study: a
vector expressing adiponectin-myc (pcDNA3.1-adiponectin-
myc) [14], FIP1GFP (pEGF-C3-FIP1) [24], FIP2-GFP (pEGFP-
C1-FIP2) [25], FIP3-GFP (pEGFP-C1-FIP3) [26], FIP4-GFP
(pEGFP-C1-FIP4 82-637) [27] and FIP5 GFP (pEGFP-C1-Rip11)
[28]. All constructs coding for Rab11 FIP proteins were a
generous gift from Dr. M. McCaffrey, University College Cork
(Ireland). The PKLO.1 puro empty plasmid (cat number
SHC001), the PKLO.1 plasmid carrying a non-targeting shRNA
(NT shRNA) sequence (cat SHC002) and PKLO.1 puro vectors
carrying shRNAs for FIP proteins were all from Sigma
(MISSION shRNA). The PMDG2 and PMCV-dR8.74 vectors to
generate the lentiviral vectors were a gift from Dr. Antonio
Zorzano (IRB, Barcelona). Biotinylated human adiponectin was
purchased from R&D; Alexa-488 conjugated transferrin was
obtained from Life Technologies.
2.2: Human subjects
We studied 233 adipose tissue samples (123 visceral and
110 subcutaneous) from a group of Caucasian subjects with a
body mass index (BMI) between 20 and 58 kg/m2 recruited at
the Endocrinology Service of the Hospital Universitari Dr.
Josep Trueta (Girona, Spain). All subjects declared that their
body mass had been stable for at least 3 months before the
study and gave written informed consent after the purpose,
nature and potential risks for the study were explained to them.
The experimental protocol was approved by the Ethics
Committee of the Hospital Universitari de Girona Dr. Josep
Trueta (Girona, Spain), so we certify that all applicable
institutional regulations concerning the ethical use of
information and samples from human volunteers were followed
during this research. Adipose tissue samples were obtained
from subcutaneous and visceral depots during elective surgical
procedures (cholecystectomy, surgery of abdominal hernia,
and gastric by-pass surgery), washed, fragmented and
immediately flash-frozen in liquid nitrogen before be stored at
-80°C.
Anthropometric measurements
BMI was calculated as mass (kg) divided by height squared
(m2). According to this anthropometric parameter, subjects
were classified as: lean (BMI<25 kg/m2) or obese (BMI ≥30
kg/m2) following World Health Organization guidelines. Serum
glucose concentrations were measured in duplicate by the
glucose oxidase method using a Beckman glucose analyzer II
(Beckman Instruments, Brea, California). Glycosylated
haemoglobin (HbA1c) was measured by the high-performance
liquid chromatography method (Bio-Rad, Muenchen, Germany,
and autoanalyser Jokoh HS-10, respectively). Intraassay and
interassay coefficients of variation were less than 4% for all
these tests. Total serum triglycerides were measured through
the reaction of glycerol-phosphate-oxidase and peroxidase on
a Hitachi 917 instrument (Roche, Mannheim, Germany). HDL
cholesterol was quantified after precipitation with polyethylene
glycol at room temperature.
2.2: Cell Culture, treatments and transfections
Cell culture of HEK293 cells and 3T3L1 cells were performed
as previously described [14]. Fully confluent 3T3L1 cells were
differentiated with insulin, IBMX and dexamethasone as
described [14]. 3T3L1 fibroblasts stably expressing shRNA
were grown in DMEM media supplemented with 10% calf
serum, and 3 µg.ml-1 of puromycin. Once confluent, cells were
differentiated in regular differentiation media. Transfections:
GFP tagged rab11-FIP expression vectors (pEGFP) myc-
tagged adiponectin (pcDNA3 vector) or plasmids carrying
shRNA sequences for FIP proteins were transfected into
HEK293 cells using lipofectamine 2000 (Life Technologies) as
per the manufacturer’s instructions. For each FIP protein a pool
of shRNA expressing vectors was transfected. The constructs
used to deplete FIP1 (rab11 FIP1C also called RCP) targeted
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all the spliced mRNAs for this protein. Isolated preadipocytes
(Zen-Bio Inc., Research Triangle Park, NC, USA) from omental
and subcutaneous adipose tissue were cultured and
differentiated for 14 days as previously described [29]. TNF-α
(100 ng/ml) and LPS-stimulated macrophage-conditioned
medium (MCM, 5%) treatments were performed during omental
and subcutaneous adipocyte differentiation as previously
described [29]. Differentiated 3T3L1 adipocytes were treated at
day 9 following differentiation with 50 ng/ml TNFα or
Interleukin-6 (IL6) or 5% (v/v) macrophage-conditioned media
as indicated in the figure legends. Macrophage conditioned
media enriched in pro-inflammatory cytokines was obtained
after stimulating human THP macrophages or mouse bone
marrow-derived macrophages with LPS (10 ng/ml) for 24hr.
Hypoxia treatments: Differentiated 3T3L1 adipocytes at day 9
of differentiation were incubated in normoxia (5% CO2, 95% air)
or under hypoxic conditions at 1% O2, 94% N2, 5% CO2 for 8,
16 or 24hr. For troglitazone (TZD) treatments, differentiated
3T3L1 adipocytes were treated with either the vehicle (DMSO)
or the PPARγ agonist (TZD) at a final concentration of 10 µM
for 3 days. Adiponectin secretion and gene expression assays
are described below.
2.3: Lentivirus production and infections
Lentiviral viruses carrying FIP specific shRNAs were
generated by cotransfecting HEK293 cells (ATTC collection)
with the PKLO.1-puro plasmid (Sigma) and the packaging
vectors PMCV-dR8.74 and PMD2G using the calcium
phosphate method. Each shRNA construct (MISSION shRNAs
from SIGMA) was transfected individually with the packaging
vectors to generate lentiviral particles each expressing a single
shRNA. The lentiviral particles used as a pool in the study
expressed shRNAs that targeted all the splicing forms for
FIP1.The media containing lentiviruses were collected 24h and
48h post transfection, centrifuged, the supernatant filtered
through a 0.45 µm filter and the media containing virus stored
at -80oC until use. To generate the stable cell lines, 3T3L1 cells
were incubated with polybrene (8 µg.ml-1) for 1 hour and
infected with all gene specific shRNA containing viruses
simultaneously. 24h post-infection the medium containing
viruses was removed and replaced with medium containing 3
µg.ml-1 of puromycin for the selection of successfully infected
cells. Media was changed every 2 days thereafter and cells
were maintained in DMEM FBS media, in the presence of 3
µg.ml-1 puromycin.
2.4: Immunofluorescence
3 T3L1 cells were fixed, permeabilized and immunostained
as previously described [14,15]. The following primary
antibodies were used: anti-FIP1 (Sigma), Anti-myc (clone
9E10, Santa Cruz Biotechnology), anti-rab11 (Life
Technologies), anti-adiponectin (R&D Minneapolis), anti-EEA1
(early endosome antigen1) (a gift from Dr. S. Urbé, University
of Liverpool), anti-Glut4 (a gift from Dr. Zorzano, IRB,
Barcelona) anti-rab5 (BD Biosciences), Alexa-350, -488 and
-594 conjugated antibodies (Life Technologies) and anti-rat
Texas Red (Abcam) were used as secondary antibodies.
Labelling of transferrin and adiponectin receptors (AdipoR1 and
R2): Cells were incubated in biotinylated adiponectin (0.04pg)
or transferrin A-594 (5µg.ml-1) containing DMEM media for 1
hour at 4°C. Media was removed and alexa-488-streptavidin
(1:100) was subsequently added for 30 minutes at 4°C in the
dark. Labelled adiponectin and transferrin receptors were
allowed to internalize at 37 °C for 5, 15, 30 or 45 minutes. Cells
were then washed twice with PBS on ice and fixed in 4% PFA /
PBS for 10 minutes. Cells were mounted and imaged in a Leica
DMI6000 microscope equipped with LAF software. Pixel
Intensity Spatial Correlation Analysis of colocalisation was
carried out using the Fiji plugin for ImageJ Software. Mander’s
coefficients of correlation M1 and M2 as well as Pearson’s
Coefficient (PC) were used for colocalisation analysis. Green
and red channel images of cells were opened by the
application and a region of interest incorporating the whole cell
was selected using the polygon selection tool. Analysis was
performed using the coloc 2 tool with a PSF of 3.0 and 10
Coste’s randomisations. Outputs indicating Mander’s
coefficients M1 and M2 and Pearson’s Coefficient (PC) were
obtained and reported as Mean ± SEM.
2.5: Western blotting
Cells were homogenised in ice-cold lysis buffer (20 mM Tris
[pH 7.8], 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1% Triton
X-100, 10% [vol/vol] glycerol, 10 mM NaF, 1 mM EDTA, 5 mM
sodium pyrophosphate, 0.5 mM Na 3VO4, 1 µg.ml-1 leupeptin,
0.2 mM phenylmethyl sulfonyl fluoride, 1 µg.ml-1 aprotinin, 1
mM dithiothreitol, 1 mM benzamidine). Samples were
incubated at 4°C for 20 minutes, centrifuged (14,000 RPM for
15 min at 4°C) and protein concentration of the supernatant
was determined using the Bio-Rad Protein Assay Kit. Samples
were separated on a SDS-PAGE, transferred to nitrocellulose
membranes, blotted in 5% non-fat milk in Tris-buffered saline
(pH 7.6) and subsequently immunoblotted with primary and
secondary antibodies. Membranes were washed in TBS -0.1%
tween buffer and visualized using chemiluminescence reagent
(Geneflow). Anti-FIP antibodies: anti-FIP1 antibody was from
Sigma, anti-FIP3 and anti-FIP5 antibodies were a generous gift
from Dr. Mary McCaffrey (UCC, Ireland) [23,26]. The anti-β-
tubulin antibody was from Sigma.
2.6: Glucose uptake
Fully differentiated 3T3L1 adipocytes were serum deprived
for 3 hours in Dulbeco Modified Eagles Media (DMEM). Cells
were then incubated in glucose depleted uptake media (20 mM
Hepes pH=7.0, 137 mM NaCl, 4.7mM KCl, 1.2 mM MgSO4, 1.2
mM KH2PO4, 2.5 mM CaCl2) for one hour. Insulin at 100nM
final concentration was added for 30 minutes and uptake was
carried out for 10 minutes in uptake solution supplemented with
1 mM 2-deoxyglucose and 3H-2-deoxyglucose (American
Radiolabeled chemicals, Inc) at 1 µCi.ml-1. Following the
uptake cells were washed 4 times in ice-cold PBS containing
50 mM cold glucose and lysed in 0.5N NaOH and an aliquot of
the lysate (200 µl) quantified for 3H-2-D-deoxyglucose and
another (10 µl) used for protein quantification.
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2.7: Secretion studies
Released and intracellular adiponectin content was
determined using an ELISA kit (R&D, Minessota) following the
manufacturer’s instructions. The portion of secreted
adiponectin was expressed as percentage of the total
adiponectin (media plus lysate).
2.8: Transferrin recycling
Transferrin recycling was assayed using fluorescence
microscopy and flow cytometry as previously described [30].
Briefly, for transferrin uptake: 3T3L1 fibroblasts were first
incubated for 30 min at 37°C in serum-free DMEM medium.
Cells were trypsinized, incubated in DMEM media containing
Alexa-488 conjugated transferrin (5 µg.ml-1) for 10 min at 4°C,
and then shifted to 37°C, and incubated for various times as
indicated. The cells were then pelleted at 4°C, washed once in
ice cold PBS and once in a buffer containing: 0.1 M glycine,
150 mM NaCl, pH=3.0. Cells were resuspended in PBS
containing 1% BSA and fluorescence quantified by flow
cytometry. For transferrin release: cells were loaded for 45 min
with transferrin at 37°C and at different time points transferred
to ice and washed in PBS/acid wash buffer as above. Cells
were resuspended in PBS containing 1% BSA and
fluorescence quantified by flow cytometry, using a FACS
Calibur, (Becton Dickinson, San Jose, CA). Data were acquired
and analyzed by using the BD CellQuestTMPro Software (BD
Biosciences, Heidelberg, Germany). The geomean was used to
plot data.
2.9: RNA extraction and Real time quantitative PCR.
Cellular studies
Total RNA was isolated using Tri reagent (Sigma) following
the manufacturer’s instructions. RNA was quantitated by
spectrophotometry and visualized in an agarose gel. Total RNA
was reverse transcribed to cDNA using Superscript VILO
reverse transcription kit (Life Technologies) as per the
maufacturer’s instructions. qPCR Primers were designed using
Primer3 Input (v.0.4.0) (http://frodo.wi.mit.edu/primer3/).
Primers were then checked for self-complementarity and
primer dimer formation by running in an agarose gel. The
efficiency of primers was then optimized for concentration and
melting temperature on a Step 1 Plus instrument (Applied
Biosystems). Samples were run in triplicate and relative
quantification was carried out using the ∆∆Ct method with
Cyclophilin A as an internal control. The primers used on these
studies were: For mouse FIP1: Forward 5’–3’:
GCTTCAGGAGGAAGCATTTG; Reverse
5-3’:CGGTAGGATGGCAAAGACAT; For Cyclophilin A :
Forward: 5’–3’: GCATACAGGTCCTGGCATCT; Reverse 5’–3’:
TTACAGGACATTGCGAGCAG. For Glut4: forward: 5’–3’:
TTCACGTTGGTCTCGGTGCTCTTA, Reverse 5’–3’:
CCACAAAGCCAAATATGGCCACGA; For Glut1: Forward 5’–
3’: TCAACGAGCATCTTCGAGAAGGCA; Reverse 5’–3’:
TCGTCCAGCTCGCTCTACAACAAA.
For the human studies: RNA was isolated using the RNeasy
Lipid Tissue Mini Kit (QIAgen). The integrity of each RNA
sample was checked by Agilent Bioanalyzer (Agilent
Technologies, Palo Alto, CA). Total RNA was reverse
transcribed to cDNA using High Capacity cDNA Archive Kit
(Applied Biosystems) according to the manufacturer’s protocol.
Real-time quantitative PCR was conducted using Light Cycler
480 Probes Master (Roche) using pre-validated TaqMan
primer/probes as follows: endogenous control PPIA (4333763,
cyclophilin A) and target genes such as RAB11 family
interacting protein 1 (RAB11FIP1, Hs00951195_m1),
peroxisome proliferator-activated receptor gamma (PPARγ,
Hs00234592_m1), adiponectin (ADIPOQ, Hs00605917_m1),
leptin (LEP, Hs00174877_m1), Insulin receptor substrate 1
(IRS-1, Hs00178563_m1) and fatty acid synthase (FASN,
Hs00188012_m1). Relative quantification was carried out using
the ∆∆Ct method using PPIA gene expression as an internal
control.
2.10: Statistical analysis
Statistical analyses were carried out using GraphPad Prism4
software (GraphPad software) and One way ANOVA analyses
were carried out with a confidence interval of 95% and
statistical significance was considered if p < 0.05. For the
human studies a T test was performed using the SPSS 12.0
software for Windows (SPSS, Chicago, IL, USA) was used. All
assays were performed at least in duplicate and reported as
mean ± SEM. The comparison between groups was performed
using two-way ANOVA followed by post-hoc analysis (using
Bonferroni post hoc tests). The relation between variables was
analyzed by bivariate correlation (Spearman’s test). For Pixel
Intensity Spatial Correlation Analysis of colocalization, SPSS
19.0 software for Windows (SPSS, Chicago, IL, USA) was
used to carry out independent T-tests and One Way ANOVA
where appropriate with statistical significance considered if p <
0.05.
Results
3.1: Expression/ knockdown of rab11 FIP1 alter
adiponectin secretion in HEK 293 cells
We have previously demonstrated that intracellular
adiponectin partially colocalizes with rab11 in adipocytes and
expression of rab11 mutants inhibited the secretion of
adiponectin [15]. To further characterize the intracellular
compartmentalization and trafficking of intracellular
adiponectin, we investigated the role of rab11 FIP effectors in
adiponectin release in HEK293 cells. We chose to carry out the
initial screening in HEK293 cells because of our previous
experience with these cells in adiponectin secretion studies
and the fact that they are easy to transfect. To this end, we first
co-expressed plasmids coding for adiponectin-myc and wild
type GFP-tagged FIPs into HEK293 cells. Transfection
efficiency in these cells was approximately 70% as determined
by GFP expression assessed by fluorescent microscopy (data
not shown). Similar levels of GFP-FIP proteins were achieved
from the expression of FIP-GFP plasmids as determined by
immunoblotting (Figure S1). As shown in Figure 1A, expression
of wild type FIP1, FIP3 and FIP5 significantly reduced
adiponectin release in HEK293 cells whereas expression of
FIP2 or FIP4 had no effect on adiponectin secretion.
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To further confirm the involvement of these rab11-FIP
proteins in adiponectin secretion we knocked down the
expression of FIP1, FIP3 or FIP5 in HEK293 cells by
expressing a pool of plasmids that carried shRNA specific
sequences for each FIP gene. Following transfection, cells
were selected in the presence of puromycin to eliminate cells
that did not incorporate the shRNAs and selected cells were
subsequently transfected with a plasmid coding for
adiponectin-myc. Cells were allowed to recover for 24 hrs and
adiponectin secretion was measured by ELISA. The efficacy
and specificity of each FIP knockdown was assessed by
immunoblotting of cellular lysates with specific antibodies
against each FIP isoform (Figure 1B). Effective downregulation
was achieved for all FIP proteins. Data from quantification of
several observations indicated a reduction at the protein level
of 60% for FIP5, 80% for FIP1 and 95% for FIP3 (Figure 1C).
We found that FIP1 (Rab11 FIP1C) depletion strongly
enhanced adiponectin secretion, whereas knock down of FIP5
Figure 1.  Rab11 FIP proteins regulate adiponectin release in HEK293 cells.  A) GFP tagged wild type RAB11-FIPs and myc
tagged adiponectin were transiently co-transfected in HEK293 cells. 24hr following transfection adiponectin was quantitated by
ELISA as indicated in the materials and methods section B) Knock down of FIP proteins in HEK293 cells. HEK293 were left
untransfected or transfected with a shRNA empty vector (pKLO.1puro) or transfected with a pool of plasmid expressing shRNA
sequences specific for FIP proteins as indicated. Whole cell lysates were obtained and protein samples were separated on SDS-
PAGE, transferred to nitrocellulose filters and immunoblotted with specific antibodies detecting the human isoforms of FIP1, FIP3
and FIP5 proteins. Anti β-tubulin antibody was used as loading control. C) Quantification of the FIP knockdown efficiency for each
FIP protein. Data are mean ± SEM from three independent experiments. D) HEK293 were transfected with a shRNA expression
(pKLO.1puro) empty vector or shRNA vectors containing shRNA sequences for FIP proteins (as indicated, mission shRNA SIGMA).
Cells were selected for 96 hours in puromycin (2 µg/ml) containing media and surviving cells were transfected with a plasmid coding
for adiponectin-myc. 24hr following transfection adiponectin was quantitated by ELISA in cell lysates and media and adiponectin
secretion was calculated as indicated in the materials and methods section. Data are means ± SEM of at least three independent
experiments Statistical analysis: One way ANOVA * indicates statistically different from control cells (p < 0.05).
doi: 10.1371/journal.pone.0074687.g001
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only mildly decreased adiponectin release and FIP3 knock
down had no effect on adiponectin secretion (Figure 1D). To
confirm that the effects on adiponectin secretion are a bona
fide consequence of the knock down of FIP1 and not the
consequence of an off-target effect of any of the shRNAs, we
expressed each of the FIP1 shRNAs constructs individually or
in pair combinations together with adiponectin-myc in HEK293
cells and as above, adiponectin secretion was determined by
ELISA. The result of these experiments is shown in Figure S2.
Cells were first transfected with FIP shRNA constructs
individually or in pair combinations or with all the shRNAs
together (indicated as ‘shRNA pool’ in Figure S2) as an internal
control. Cells incorporating the plasmids were selected in
puromycin, and surviving cells were transfected with a
construct expressing adiponectin-myc and allowed to recover
for 24 hrs prior to measuring adiponectin secretion. We found
that neither the expression of single nor double combinations of
the FIP1 shRNA plasmids were able to increase adiponectin
secretion above the amount seen in control cells expressing
only the adiponectin-myc plasmid or adiponectin-myc and the
shRNA empty vector (Figure S2 panel A). Importantly, neither
single or double transfections of FIP1 shRNA constructs
resulted in depletion of FIP1 protein expression (Figure S2
panel B), as this was only achieved when all the shRNAs were
used in combination (Figure S2. panel B, lanes 11 and 12).
These data confirmed that the effects seen on adiponectin
secretion are not caused by an off-target effect of these
shRNAs but rather the depletion of FIP1 expression when all
the shRNAs are used in combination. In subsequent
experiments we sought to confirm and further determine the
function of FIP1 in adiponectin trafficking in adipose cells.
3.2: FIP1 depletion increases adiponectin secretion in
differentiated adipocytes
To investigate whether FIP1 plays a role in adiponectin
secretion in adipocyte cells, we first examined the intracellular
distribution of FIP1 (rab11 FIP1C) in adipocytes. To this end,
fully differentiated 3T3L1 adipocytes were fixed, permeabilized
and immunostained with antibodies to detect endogenous FIP1
and adiponectin proteins. As shown in Figure 2 localization of
FIP1 partially overlapped with that of endogenous adiponectin
(Figure 2, panel c). Analysis revealed a high degree of FIP1
and adiponectin colocalisation (M1 0.99 ± 0.001, M2 0.95 ±
0.012, PC 0.67 ± 0.018).
To examine whether FIP1 functions in adipocytes to regulate
adiponectin secretion, we next generated stable adipose cell
lines with depleted expression of FIP1 by constitutively
expressing shRNAs for FIP1 or a non-targeting shRNA (NT
shRNA) sequence as control. To achieve this, undifferentiated
3T3L1 cells were infected with a pool of lentiviral vectors each
expressing a shRNA sequence for FIP1 or a non-targeting
shRNA construct. As with the human FIP1 the constructs used
for targeting FIP1 protein in mouse targeted all the isoforms of
rab11 FIP1C. Infected cells were selected in the presence of
puromycin and subsequently differentiated to obtain adipocyte
cells. Expression of FIP1 was assessed by real time PCR
analysis and western blot (Figure 3A). Expression of a non-
targeting shRNA did not reduce the mRNA levels of FIP1 in
adipocytes, however mRNA levels for FIP1 were reduced by
80% in the FIP1 shRNA expressing cells compared to control
non-infected (Figure 3A, left panel). At the protein level, FIP1
expression was reduced by 96% in shRNA expressing cells
(Figure 3A, middle and right panels) compared to non-infected
adipocytes. We then examined the total amount and the
secretion of endogenous adiponectin in uninfected cells, in
cells expressing non-targeting shRNAs or FIP1 shRNAs. The
expression of non-targeting shRNAs did not alter adiponectin
content or secretion. In contrast, adipocytes expressing FIP1
shRNAs displayed a small (16%) but significant decrease in the
total amount of adiponectin (Figure 3B), yet, despite this, these
cells exhibited an increase in adiponectin secretion of
approximately 20% (Figure 3C). Taken together with the data
from HEK293 cells, these results suggest that FIP1 is involved
in regulating adiponectin trafficking and secretion in adipocytes.
Figure 2.  Intracellular distribution of FIP1, and adiponectin in adipocytes.  3T3L1 cells were cultured and differentiated to
adipocytes as described in the methods section. Cells were fixed, permeabilized and immunostained with anti-FIP1 (Sigma) and
anti-adiponectin (R and D) primary antibodies and Alexa-488 and Alexa-594 –conjugated secondary antibodies. Data shown is
representative of cells obtained from three independent sets of cells. Determination of colocalization was carried out as described (n
= 27).
doi: 10.1371/journal.pone.0074687.g002
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To confirm that the changes seen in adiponectin synthesis
and secretion observed in FIP1 knock down cells were not due
to alterations in the differentiation of the cells, we examined
lipid accumulation by oil red staining and the expression and
recruitment to the plasma membrane of the facilitative glucose
transporter Glut4 in response to insulin. FIP1 depleted cells
exhibited a similar differentiation to control cells as judged by
phase microscopy and lipid accumulation (Figure 4A). These
cells exhibited comparable expression levels of the glucose
transporter Glut4 (not shown) and responded to insulin
treatment in a comparable manner to control cells, by
redistributing the glucose transporter Glut4 to the plasma
membrane and stimulating glucose uptake in response to
insulin (Figure 4B). These findings suggest that adipocyte
differentiation and Glut4 traffic are not affected by FIP1 knock
down.
To further evaluate the role of FIP1 in regulating adipocyte
endosomal trafficking we assessed recycling of transferrin
Figure 3.  Knock down of FIP1 in 3T3L1 adipocytes increases adiponectin secretion.  3T3L1 cell lines stably expressing non-
targeting shRNAs or shRNAs for FIP1 were generated as described in the methods section. Cells were cultured in the presence of
3-5 µg/ml puromycin to select for shRNA expressing cells and subsequently differentiated into adipocytes and used on day 10 after
differentiation. A) Knock down of FIP1 in adipocytes. Left panel: total RNA was extracted from control (uninfected), non-targeting
shRNA expressing and FIP1 shRNA expressing cells, and the mRNA for FIP1 was quantified by qPCR. Gene expression was
normalized to Cyclophilin A using the ΔΔCT method. Graph is the mean ± SEM of 3 independent experiments each quantified in
triplicate. Statistical analysis: one way ANOVA. *indicates p<0.05 relative to control cells. Middle panel: Cell lysates were obtained
from differentiated control (non-infected) cells, cells expressing FIP1 specific shRNAs or non-targeting (NT) shRNAs. Samples were
separated by SDS-PAGE, transferred to nitrocellulose filter and immunoblotted with an anti-FIP1 antibody or anti β-tubulin antibody
as shown. The right panel shows quantification of the western blot normalized to tubulin. Statistical analysis: one way ANOVA, **
indicates p<0.01 relative to control non-infected cells. B) Adiponectin expression. Total intracellular adiponectin content was
determined in control (non-infected) cells, in cells expressing non-targeting shRNAs or shRNAS for FIP1. Cellular lysates were
obtained from fully differentiated cells, and adiponectin content quantified as described in the methods section. Data from two
independent experiments, with n=5 replicates each. Data are mean ± SEM. * Statistic analysis: one way ANOVA, * indicates p<0.05
relative to control cells. C) Adiponectin secretion. Culture media and cell lysates were obtained from control cells (non infected),
non-targeting shRNA expressing cells, or FIP1-depleted cells the amount of adiponectin quantitated using ELISA. Secretion was
calculated as indicated in the methods section. Secretion is expressed as a percentage of total adiponectin expressed. Data from
two independent experiments, with n=5 replicates each. Data are mean ± SEM. * indicates statistically different from control cells (p
< 0.05). NT shRNA = non-targeting shRNA.
doi: 10.1371/journal.pone.0074687.g003
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receptors in control uninfected cells or FIP1 depleted cells. To
this end, cells were incubated with Alexa488-conjugated
transferrin on ice for 10 minutes. Transferrin occupied
receptors were then allowed to internalize at 37°C for different
lengths of time ranging from 0 to 30 minutes. At each time
point, cells were washed and the amount of intracellular
fluorescence quantified by flow cytometry. As seen in Figure
4C, we did not observe any differences in the transferrin uptake
rates in cells depleted of FIP1 compared to control cells. We
then determined the exocytosis of transferrin receptors
following a pre-loading with Alexa-488 transferrin for 30
minutes at 37°C. Transferrin release was carried out at 37°C, at
different time points cells underwent washes as described in
the methods, and the intracellular accumulation of fluorescently
labeled transferrin determined by flow cytometry. We found that
the release of transferrin was no different in FIP1 knock down
cells compared to control cells (Figure 4C). These findings
suggest that FIP1 knock down does not alter the cycling of
transferrin receptors in adipocytes.
Figure 4.  Knock down of FIP1 does not alter adipogenesis, insulin-stimulated Glut4 translocation or transferrin receptor
recycling.  Control 3T3L1 cells (non-infected), and 3T3L1 cell lines stably expressing a non-targeting shRNA or shRNAs for FIP1
were cultured and differentiated to adipocytes and used on day 10 after differentiation. A) Cells were fixed and stained with oil red
and visualized under a light microscope. Images were taken in a Leica microscope. Representative images are shown from at least
three independent experiments. Oil red stain was extracted in isopropanol and the absorbance quantified at 500 nm. B) Cells were
serum starved in DMEM for 3 hours and either left untreated or treated with insulin (100 nM) for 30 minutes. 3H-2-deoxyglucose
uptake was then measured for 10 minutes as indicated in the material and methods section. 3H -2-deoxyglucose uptake at 1 mM
final concentration for 10 minutes is within the linear range in these cells (not shown) C) Transferrin recycling. Transferrin uptake:
control and FIP1 Knock down 3T3L1 cells were incubated with Alexa-488 conjugated transferrin as indicated in the methods
section. At different time points cells were washed and the intracellular fluorescence determined by flow cytometry. Transferrin
release: Cells were first loaded with Alexa-488 transferrin for 45 minutes at 37°C and then washed at different time points as
indicated. Cells were collected and intracellular fluorescence quantitated by flow cytometry as described in the methods section.
Results show mean ± SEM of 2 independent experiments quantified in triplicate.
doi: 10.1371/journal.pone.0074687.g004
Regulation of Adiponectin Secretion by Rab11 FIP1
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e74687
3.3: FIP1 Knock down does not impair trafficking of
adiponectin to the Early/Sorting endosome (EE/SE) or
recycling endosome (ERC)
To shed some light on the mechanism of action of FIP1 and
to rule out that the increase in secretion of adiponectin is due to
mistargeting of intracellular adiponectin in the FIP1 depleted
cells, we next examined the intracellular compartmentalization
of adiponectin in the FIP1 knock down adipocytes, and
compared it to that of non-infected control cells or cells
expressing the non-targeting shRNAs. First, we determined the
distribution of endogenous adiponectin and rab11. We found
that intracellular adiponectin co-distributed with rab11 in control
cells (M1 0.96 ± 0.02, M2 0.95 ± 0.01, PC 0.81 ± 0.02), in cells
expressing the non-targeting shRNA construct (M1 0.96 ± 0.02,
M2 0.99 ± 0.001, PC 0.80 ± 0.04) and in FIP1 knock down cells
(M1 0.98 ± 0.01, M2 0.98 ± 0.01, PC 0.87 ± 0.03) (Figure 5,
merged images, panels c, f, and i). Statistical analysis
(ANOVA) revealed no differences in the colocalization levels of
adiponectin and Rab11 between control, non-targeting shRNAs
and FIP1 depleted cells (p > 0.05). These results demonstrate
that FIP1 depletion does not prevent traffic of endogenous
adiponectin to the ERC.
It has been reported that in addition to rab11 FIP1 can also
interact with rab14 [23]. We examined whether endogenous
adiponectin distributed with intracellular rab14 in control or
FIP1 depleted adipocytes. We found that endongenous
adiponectin partially overlapped with that of rab14 in
differentiated 3T3L1 adipocytes (Figure S3), but no differences
(p > 0.05) were seen between control (M1 0.72 ± 0.09, M2 0.98
± 0.01, PC 0.55 ± 0.07) or FIP1 depleted adipocytes (M1 0.73
± 0.10, M2 0.97 ± 0.01, PC 0.53 ± 0.10).
Since previous observations also suggested that adiponectin
partially colocalized with rab5 in the early/sorting endosome
(EE/SE) [15], we next compared the distribution of adiponectin
with markers for the EE/SE (rab5 and EEA1 –early endosome
antigen1-) in control or FIP1 knock down adipocytes. In control
cells adiponectin distribution overlapped with that of rab5 (M1
0.97 ± 0.02, M2 0.89 ± 0.02, PC 0.67 ± 0.03) and EEA1
proteins (M1 0.91 ± 0.03, M2 0.99 ± 0.01, PC 0.61 ± 0.07)
(Figure 6, panel d). This distribution was maintained in the FIP1
knock down cells (rab 5: M1 0.99 ± 0.0002, M2 0.92 ± 0.0019,
PC 0.85 ± 0.022; EEA1: M1 0.96 ± 0.01, M2 0.94 ± 0.06, PC
0.61 ± 0.06) (Figure 6, panel h). These results demonstrate
Figure 5.  Knock Down of FIP1 does not impair traffic of adiponectin to the ERC compartment.  Control uninfected 3T3L1
cells or expressing non-targeting shRNAs or FIP1- shRNAs cultured and differentiated to adipocytes and used on day 10 after
differentiation. Cells were fixed, permeabilized and stained with specific antibodies to detect endogenous rab11 and adiponectin
proteins. Secondary antibodies conjugated to Alexa-488 or Alexa-594 respectively were used to visualize the proteins. Cells were
visualized using a Leica DMI6000 microscope. Representative cells from 3 independent experiments are shown. Determination of
colocalization was carried out as described (Control (n = 10), FIP1 shRNA (n = 9), NT shRNA (n = 4)). Panels c, f and i show the
merged images.
doi: 10.1371/journal.pone.0074687.g005
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that FIP1 depletion does not prevent traffic of endogenous
adiponectin to the early endosome.
Since cargo from the ERC/EE can be delivered to the late
endosome (LE) for degradation we next evaluated the
possibility that FIP1 may be regulating traffic of adiponectin to
the late endosome. To this end, we evaluated the intracellular
distribution of adiponectin and Lamp1, a marker for the late
endosome, in control or FIP1 depleted adipocytes. As shown in
Figure 7 we found that intracellular distribution of adiponectin
was not overlapping with that of Lamp1 (Figure 7, merged
panels c and f). These findings suggest that adiponectin does
not traffic from the EE/ERC to the late endosome.
3.4. FIP1 knockdown does not impair internalization of
adiponectin receptors
Since adipocytes express high levels of adiponectin
receptors, and since a fraction of released adiponectin can be
internalized through binding to these receptors, we tested the
possibility that FIP1 knock down could prevent internalization of
adiponectin receptors. To this end we labeled adiponectin
receptors with biotinylated adiponectin and used Alexa-592
conjugated transferrin to monitor internalization of transferrin
receptors as control. Cells were incubated with the ligands on
ice for 30 minutes followed by incubation with streptavidin-
conjugated Alexa-488. Cells were then transferred to 37°C and
the adiponectin and transferrin occupied receptors were
allowed to internalize for different lengths of time ranging from
5 to 45 minutes. Cells were then washed in PBS, fixed and
imaged on an epifluorescent microscope. Our results
demonstrate that FIP1 knock down cells display substantial
expression of adiponectin receptors and that these internalize
and co-distribute intracellularly with transferrin receptors
(Figure 8). No differences were observed in the intracellular
distribution of adiponectin receptors between control cells and
FIP1 depleted cells (Figure 8).
3.5: FIP1 expression is downregulated during
adipogenesis and by treatment with thiazolidinediones
Adiponectin levels increase during adipocyte differentiation
and by treatment with the PPARγ agonists thiazolidinediones
[31] [32]. To further assess the physiological relevance of FIP1
function we sought to determine whether FIP1 expression
parallels with that of adiponectin in these conditions.
To this end we first examined the expression of FIP1 in
undifferentiated and differentiated 3T3L1 cells. We found that
FIP1 protein (Figure 9A and B) and mRNA levels (Figure 9,
panel B) decreased with the differentiation of 3T3L1 cells to
adipocytes.
In order to confirm these data, we treated fully differentiated
adipocytes with troglitazone, a thiazolidinedione that functions
as a Peroxisome Proliferator-Activated Receptor gamma
(PPARγ) agonist. PPARγ together with the transcription factor
Figure 6.  Knock down of FIP1 does not impair traffic of adiponectin to the sorting endosome.  Control, uninfected 3T3L1
cells, or cells stably expressing shRNAs for FIP1 were cultured and differentiated to adipocytes and used on day 10 after
differentiation. Cells were fixed, permeabilized and stained with specific antibodies to detect endogenous EEA1, Rab5 and
adiponectin proteins. Secondary antibodies conjugated to Alexa-350, Alexa-488 and Alexa-594 were used to visualize the proteins.
Cells were imaged in a Leica DMI6000 microscope. Representative cells are shown obtained in three independent experiments.
Determination of colocalization was carried out as described (Rab 5: Control (n = 9), FIP1 shRNA (n = 7); EEA1: Control (n = 10),
FIP1 shRNA (n = 11) Panels d and h show the merged images.
doi: 10.1371/journal.pone.0074687.g006
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Figure 7.  Adiponectin does not localize with Lamp1 containing membranes in adipocytes.  Control (uninfected) 3T3L1 cells
or cells expressing shRNAs for FIP1 were cultured and differentiated to adipocytes and used on day 10 after differentiation. Cells
were fixed, permeabilized and stained with specific antibodies to detect endogenous adiponectin or lamp1. Secondary antibodies
conjugated to Alexa488 and Alexa594 were used to visualize the proteins. Representative cells are shown from 3 independent
experiments. Panels c, and f show the merged images.
doi: 10.1371/journal.pone.0074687.g007
Figure 8.  Adiponectin receptors are internalized and localize with transferrin receptor in intracellular membranes.  Control
uninfected 3T3L1 cells or cells expressing shRNAs for FIP1 were cultured and differentiated to adipocytes and used on day 10 after
differentiation. Cells were labelled with biotin-adiponectin and Alexa-594 conjugated transferrin at 4°C for 30 minutes and then
incubated in Alexa488-streptavidin. Internalization of adiponectin and transferrin bound receptors was allowed at 37°C for the times
as indicated. Cells were then transferred to ice, and fixed in PFA as detailed in the methods section. Cells were imaged in a Leica
DMI6000 microscope. Data shown are the merged images. Representative cells are shown selected from three independent
experiments.
doi: 10.1371/journal.pone.0074687.g008
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C/EBPs (CCAAT/enhancer-binding proteins) play a crucial role
in regulating the differentiation programme in adipocytes
regulating many lipid and glucose homeostatic genes. Since
thiazolidinediones potentiate adipocyte differentiation we
postulated that troglitazone would reduce the expression of
FIP1 in adipocytes. Treatment of fully differentiated adipocytes
with troglitazone increased adiponectin secretion (Figure 9C
 left panel) and as expected reduced the expression of FIP1
(Figure 9C, right panel). Taken together these data suggest
that FIP1 protein is reduced during adipocyte cell differentiation
possibly via the activation of PPARγ.
Figure 9.  FIP1 expression decreases during adipogenesis, and by treatment with troglitazone.  A) Cell lysates were obtained
from 3T3L1 fibroblasts (F) or fully differentiated adipocytes (A). Samples were separated by SDS-PAGE, transferred to a
nitrocellulose filter and immunoblotted with an anti-FIP1 or β-tubulin antibody as shown. Representative blot of two independent
experiments. B) Quantification of FIP1 protein levels (left panel) or FIP1 mRNA levels (right panel) following the differentiation of
3T3L1 cells to adipocytes. Data shows mean ± SEM of triplicate values. Statistic analysis: One way ANOVA * indicates p<0.05. C)
3T3L1 cells were cultured and differentiated to adipocytes. At day 8 of differentiation, cells were either left untreated or treated with
vehicle or with 10 µM troglitazone for 3 days. Conditioned media and cellular lysates were harvested for adiponectin quantification
by ELISA as described in the methods section A subset of cell plates were used for total RNA isolation and mRNA for FIP1 was
quantified by real time PCR as described in the methods section. Data shows mean ± SEM of 2 independent experiments each
performed in triplicate. Statistical analysis, one way ANOVA: * indicates p<0.05.
doi: 10.1371/journal.pone.0074687.g009
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3.6: FIP1 expression inversely correlates with BMI and
obesity markers in humans
Since adiponectin levels decrease in obesity and type 2
diabetes [33], we sought to determine whether FIP1 expression
in adipose tissue is altered in obesity in humans. To this end,
we analyzed 233 adipose tissue samples, 123 visceral (VAT)
and 110 subcutaneous (SAT), obtained from subjects with a
body mass index (BMI) ranging between 20 and 58 kg/m2. We
correlated the gene expression of FIP1 with obesity markers
and with several genes involved in lipid metabolism and insulin
signaling.
Interestingly we found that gene expression of FIP1 was
significantly increased in visceral compared with subcutaneous
adipose tissue (0.029 ± 0.009 vs. 0.023 ± 0.008, p<0.0001).
We also found that FIP1 expression inversely correlated with
triglyceride levels and positively correlated with mRNA levels of
insulin receptor substrate-1, a protein involved in insulin
signaling in both SAT and VAT (Table 1). In SAT there was an
inverse relationship between both BMI and mRNA leptin levels
and FIP1 gene expression, however, these associations were
not significant in VAT (Table 1). When subjects were classified
according to their BMI, significant reductions in FIP1
expression were seen in obese (BMI>30 kg/m2) subjects
(Figure 10) when compared with lean or non-obese individuals.
Taken together these data support our in vitro observations in
that less FIP1 expression is found in more mature adipocytes
that accumulate more lipids, and highlight the physiological
importance of the regulation of FIP1 expression in adipocytes.
3.7. FIP1 expression increases with exposure to the
pro-inflammatory cytokine tumor necrosis factor alpha
(TNFα).
To gain further insights into the regulation of FIP1 expression
in adipose tissue and during adipose tissue dysfunction as it
occurs in obesity we cultured human adipose cells in the
Table 1. Bivariate correlation between sex-adjusted
RAB11FIP1 gene expression, antropometric and clinical
parameters, and expression of selected genes.
 SAT VAT
 r p r p
Age (years) -0.083 0.5 0.05 0.6
BMI (kg/m2) -0.22 0.03 -0.11 0.25
Fasting glucose (mmol/l) -0.01 0.8 -0.035 0.7
HbA1c (%) 0.08 0.5 0.04 0.07
HDL-Cholesterol (mg/dl) 0.20 0.04 0.11 0.4
Fasting triglycerides (mg/dl) -0.03 0.7 -0.22 0.03
PPARγ (R.U.) 0.11 0.37 0.12 0.36
IRS1 (R.U.) 0.33 0.005 0.24 0.03
LEP (R.U.) -0.34 0.005 -0.15 0.2
FASN (R.U.) 0.24 0.03 0.10 0.4
Sample size: N=123 (VAT) and N=110(SAT)
R.U.: relative units of gene expressionSAT: Subcutaneous adipose tissue; VAT:
Visceral adipose tissue
doi: 10.1371/journal.pone.0074687.t001
absence or presence of the pro-inflammatory cytokine TNFα or
in media supplemented with 5% (v/v) of macrophage
conditioned media obtained after stimulating THP
macrophages with LPS for 24hrs. As seen in Figure 11,
exposure of differentiated adipocytes from visceral (panel A) or
subcutaneous origin (panel B), to either TNFα or to
macrophage conditioned media resulted in a significant
increase in FIP1 expression. Concomitantly with this, and
consistent with literature findings [34], adiponectin mRNA
levels were decreased by exposure to pro-inflammatory
cytokines (Figure 11 A and B right panels). We confirmed these
findings in the mouse cell line 3T3L1, by incubating
differentiated 3T3L1 adipocytes in the presence of TNFα or
interleukin-6 (IL-6) for 24 hrs. As control for this experiment we
determined the mRNA levels of the glucose transporter Glut4,
which has been reported to decrease with exposure to TNFα
[34,35] or to IL-6 [36]. We found that TNFα increased FIP1
mRNA levels in 3T3L1 adipocytes while profoundly decreased
Glut4 mRNA levels (Figure 11C). No significant changes were
observed in adipocytes treated with IL-6 (Figure 11C).
Hypoxia has been reported to be a factor regulating
adipokine and cytokine production by adipose tissue in obesity.
Therefore to further confirm these findings we determined the
expression of mRNA for FIP1 in cells cultured under hypoxic
conditions (1% Oxygen, 5% CO2 and 94% N2) for 8, 16 or 24
Figure 10.  Expression of FIP1 mRNA in subcutaneous
adipose tissue in association with obesity
status.  Expression of FIP1 gene in human adipose tissue
biopsies was quantified as described in the methods section
and correlated with BMI (body mass index). Subjects were
classified as non-obese if BMI<30 kg/m2(N=21) and obese if
BMI>30 kg/m2(N=55). Diabetic patients were excluded.
Boxplots showing the median, interquartile range, outliers, and
extreme cases. Statistical analysis T-test, p=0.026.
doi: 10.1371/journal.pone.0074687.g010
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Figure 11.  Pro-inflammatory cytokines increase the expression of FIP1 in adipocytes.  Human preadipocyte cells from
omental (A) or subcutaneous (B) adipose tissue were obtained from Zen-Bio and differentiated as per their instructions for 14 days.
A subset of cells were left untreated (control, C) or were incubated in media supplemented with macrophage conditioned media
(MCM, 5% v/v) or with 100 ng/ml of Tumor necrosis factor alpha (TNFα), Total RNA was isolated and FIP1 and adiponectin mRNA
was quantitated by real time PCR as indicated in the methods section. Relative quantification was carried out using the ∆∆Ct
method using PPIA gene expression as an internal control. Statistical analysis: One way ANOVA. * indicates statistical significance
p<0.05. Data from one experiment with triplicate cell dishes. C) Fully differentiated 3T3L1 adipocytes were incubated in the absence
(control, C) or presence of TNFα (TNFα) or Interleukin 6 (IL6) at 50 ng/ml for 24 hours, Total RNA was isolated and the amount of
mRNA for FIP1, or Glut4 was determined by real time PCR. Quantification was carried out using the ∆∆Ct method using cyclophyllin
A as internal control. The graph shows data from a representative experiment of two independent experiments each carried out with
triplicate cell dishes for each group. Statistical analysis: One way ANOVA, ** indicates p<0.01.
doi: 10.1371/journal.pone.0074687.g011
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hours and compared it to that of cells cultured under normoxic
conditions (5% CO2, 95% air). As positive control for the
hypoxia treatment we measured the mRNA abundance of the
glucose transporter Glut1 which is known to be increased
under hypoxic conditions. As expected, hypoxia raised the
mRNA levels of Glut1 (Figure S4, panel B). There was a
tendency for the cells exposed to hypoxic conditions to have
higher FIP1 mRNA levels compared to normoxic cells but the
differences did not reach statistical significance (Figure S4,
panel A).
Taken together these findings indicate that TNFα contributes
to regulate FIP expression in adipocytes.
Discussion
We have previously reported that endosomes constitute an
important compartment for the regulation of adiponectin
secretion in cultured and rat isolated adipocytes. We previously
described that intracellular adiponectin partially colocalizes with
both rab5- and rab11-containing endosomes and either
expression of rab5 or rab11 mutants, or chemical ablation of
the endosomes, significantly reduces adiponectin release in
adipocytes [15]. Here we set out to investigate the role of the
rab11 family of interacting proteins (FIPs) in adiponectin
trafficking and secretion.
Overexpression of FIP1, FIP3 or FIP5 in HEK293 cells
inhibited adiponectin release whereas expression of FIP2 or
FIP4 had no effect. Therefore, it is unlikely that FIP2 or FIP4
play a role in adiponectin secretion. While FIP3 overexpression
in HEK293 cells resulted in a decrease of approximately 40%
in adiponectin secretion, FIP3 depletion had no effect. Recent
findings by Horgan et al., indicate that FIP3 overexpression
fragments the Golgi compartment [37], and thus, it is likely that
the decrease in adiponectin secretion observed by the
overexpression of FIP3 is caused indirectly by the disruption of
the Golgi apparatus. The lack of effect observed in the knock
down condition suggests FIP3 does not play a role in
adiponectin secretion and supports this theory. In our study,
FIP5 overexpression in HEK293 cells resulted in a modest
decrease in adiponectin secretion of approximately 35%,
whereas FIP5 knock down decreased secretion by
approximately 25%. However, much bigger effects were seen
with FIP1. Overexpression of FIP1 in HEK293 cells decreased
adiponectin release by approximately 55%, whereas knock
down increased secretion by 70%. In 3T3L1 adipocytes
intracellular distribution of FIP1 overlapped with that of
endogenous adiponectin and crucially the effect of FIP1
depletion on adiponectin secretion was maintained albeit to a
lesser degree (~20% increased secretion). Importantly
however, the expression of FIP1 is severely downregulated
during adipogenesis, thus the reduced effect of FIP1 knock
down may be explained by the already reduced levels of FIP1
protein in adipocytes.
Concomitantly with increased adiponectin secretion in FIP1
depleted adipocytes we observed a small (~16%) but
significant decrease in total adiponectin levels. As we find
greater adiponectin secretion in this model, this may lead to a
reduction in intracellular adiponectin. Adiponectin can also
regulate its own production via binding to its receptor in
adipocytes [38]. Furthermore, recent findings also suggest that
adiponectin can modulate the expression of other adipokines in
adipocytes, which in turn, could have an effect on adiponectin
expression [39].
We found that FIP1 knock down in adipocytes increased
adiponectin release without affecting the delivery of intracellular
adiponectin from the trans-Golgi network to the SE/EE, or to
the ERC. FIP1 knock down did not affect transferrin receptor
recycling or exocytosis of the Glut4 glucose transporter in
response to insulin. Our findings agree with those reported by
Peden et al. [40], who found that FIP1 knock down in HeLa
cells did not alter transferrin recycling. These authors however,
found reduced levels of transferrin receptors in FIP1 knock
down cells, which was prevented by lysosomal protease
inhibitors, indicating that FIP1 could have a role in the sorting
of transferrin receptors at the ERC away from the degradative
pathway. While we did not quantify transferrin receptor
expression in our adipocytes, our immunofluorescence
experiments failed to detect any colocalization of adiponectin
with Lamp1, a marker for the late endosome, in FIP1 depleted
cells or indeed in control cells, suggesting adiponectin is not
delivered to the late endosome. We found that adiponectin
receptors internalize with transferrin receptors in adipocytes but
there were no differences in the intracellular distribution of
adiponectin receptors between control or FIP1 knock down
cells. Furthermore, no differences were observed in transferrin
receptor recycling rates. Taken together these data suggest
that FIP1 is not regulating endocytosis of adiponectin
receptors. Recently, Jing et al. [41], have reported a role for
FIP1 in regulating traffic of selected cargo from the ERC to the
TGN. Thus, it is also possible that the retention of adiponectin
by FIP1 in adipocytes may involve the TGN. In any case, our
secretion data obtained both in HEK293 and adipocytes is
consistent with a role for FIP1 in the intracellular retention of
adiponectin.
FIP1 has been shown to bind to both rab11 and rab14 [23].
We found that the distribution of endogenous adiponectin
partially overlaps with that of rab14 in adipocytes. This
suggests that the actions of FIP1 in regulating adiponectin
secretion may be in part carried out through the interaction of
FIP1 with rab14. However, further experiments are needed to
evaluate the specific contributions of rab14 to adiponectin
secretion which we plan to follow up in future studies.
Adiponectin is only expressed in fully differentiated
adipocytes. Consistent with the above role of FIP1 in regulating
adiponectin trafficking and secretion we found that FIP1 mRNA
and protein levels are downregulated during adipocyte
differentiation. Two families of transcription factors are key
regulators of the adipogenic programme: the CCAAT/
enhancer-binding proteins (C/EBPs) and the peroxisome
proliferator-activated receptors (PPARγ). Treatment of
differentiated adipocytes with the thiazolidinedione (TZD),
troglitazone, a PPARγ agonist also reduced FIP1 levels while
increased adiponectin secretion. While similar effects of TZDs
on adiponectin secretion had been reported previously
[32,42,43], the contribution of TZDs to regulating membrane
traffic events in adipocytes have not been extensively studied.
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In a recent study, Martinez et al. 2010 [44] found that
rosiglitazone, another TZD, enhanced endosomal traffic and
increased Glut4 and transferrin receptor levels at the cell
surface. Our results are in line with these data and suggest that
TZDs may regulate adiponectin release via reduction of FIP1
protein. However, whether PPARγ exerts its effects on FIP1
gene directly or indirectly remains to be further investigated. At
this time further experiments are needed to confirm this
hypothesis.
We show that FIP1 expression was reduced in subcutaneous
adipose tissue of obese subjects. In this study, FIP1 mRNA
was inversely correlated with BMI, leptin and fasting triglyceride
levels, reflecting a reduced expression of FIP1 in mature lipid-
loaded adipocytes, in line with our in vitro adipogenesis data.
Obesity is associated with compromised adiponectin synthesis
and release [1]. However, the molecular mechanisms that lead
to the regulation of FIP1 gene in human adipose tissue are
currently unknown and warrant further investigation. During
obesity an increased lipid accumulation and adipose cell
expansion leads to adipose tissue hypoxia and subsequent
adipose tissue dysfunction characterized by metabolic
abnormalities, and significant alterations in the overall
adipokine tissue profile. In obese adipose tissue, increased
macrophage infiltration and activation leads to enhanced
production and release of pro-inflammatory cytokines. We
tested the hypothesis that proinflammatory cytokines could act
on adipose tissue to modulate the expression of FIP1. We
found that in vitro treatment of human or mouse adipocytes
with tumor necrosis factor alpha (TNFα) or with LPS-stimulated
macrophage-conditioned media, enriched with pro-
inflammatory cytokines, increased FIP1 expression at the same
time that it decreased adiponectin levels. Macrophage-
conditioned media also increased the expression of interleukin
6 (IL-6) in human adipocytes (data not shown), however we did
not see any effect of IL-6 on FIP1 expression in mouse
adipocytes. Our findings agree with previous reports that
showed TNFα downregulates adiponectin mRNA levels [34,45].
Interestingly, TNFα has been shown to downregulate the
transcriptional activator PPARγ both by reducing its mRNA
levels [34] and by reducing its transcriptional activity, causing
serine phosphorylation of key regulatory residues in its N
terminal domain [46,47]. While we did not directly examine the
molecular mechanisms by which TNFα induced FIP1
expression it is tempting to speculate that it may be mediated
in part by inhibition of PPARγ.
Hypoxia induces changes in the expression of many
adipokines and has been recently shown to directly reduce the
secretion of adiponectin in adipocytes [48]. In our study we
found a tendency for FIP1 mRNA levels in 3T3L1 adipocytes to
increase when cultured in hypoxic conditions, although the
differences observed did not reach statistical significance.
Hypoxia increased the expression of pro-inflammatory
cytokines including IL-6 and TNFα in primary adipose and
macrophages in vitro [49] and decreased adiponectin mRNA
levels in adipocytes [49]. Hypoxia treatment increased TNFα
release in stromal cells isolated from human obese visceral
adipose tissue [50]. It is possible that the hypoxia treatment in
our in vitro study did not enhance TNFα expression to sufficient
levels necessary to modulate FIP1 expression in the 3T3L1
adipocyte cell line. Nevertheless, in vivo adipose tissue hypoxia
may contribute to increase FIP1 expression and impair
adiponectin release indirectly via upregulation of TNFα in
infiltrated or adipose tissue resident macrophages. During
obesity a complex interplay of local cytokines may ultimately
affect FIP1 expression in adipocytes. In future studies it will be
interesting to test whether anti-inflammatory cytokines can
reduce FIP1 expression and enhance adiponectin release in
adipocytes.
In sum, our experimental findings demonstrate that FIP1
regulates intracellular adiponectin trafficking and secretion in
adipocytes. FIP1 expression is regulated during adipogenesis,
obesity and thiazolidinedione treatment. We postulate that FIP1
may be involved in retaining adiponectin within the endosomal
system of adipocytes or between the ERC and TGN. Further
investigation is needed to elucidate the molecular basis for this
action and to identify the downstream molecular partners for
FIP1.
Supporting Information
Figure S1.  Expression of FIP-GFP proteins in HEK293.
Plasmids expressing GFP-tagged wild type RAB11-FIPs and
myc-tagged adiponectin were transiently co-transfected in
HEK293 cells as indicated in the methods section. 24hr
following transfection cell lysates were obtained and separated
by SDS-PAGE, transferred to a nitrocellulose filter and
immunoblotted with an anti-FIP antibody or tubulin as
indicated. Lanes1-2: cells expressing FIP1-GFP; lanes 3-4:
cells expressing FIP2-GFP; lanes 5-6: cells expressing FIP3-
GFP; lanes 7-8; cells expressing FIP4-GFP; lanes 9-10: cells
expressing FIP5-GFP. Representative blot of three
independent experiments.
(TIF)
Figure S2.  Adiponectin secretion in cells expressing
single or paired FIP1 shRNA constructs. HEK293 cells were
transfected with single FIP shRNA constructs or in paired
combinations as described in the methods section. Transfected
cells were selected in the presence of 5 µg/ml of puromycin for
3 days. Cells were then transfected with a plasmid coding for
adiponectin-myc and 20 hrs following transfection the media
and cellular lysates were harvested and the amount of
adiponectin quantitated by ELISA as indicated in the methods
section. Controls: cells transfected only with the plasmid coding
for adiponectin-myc, cells transfected with adiponectin-myc and
the shRNA empty vector or cells transfected with the pool of
FIP1 shRNAs in combination ’shRNA pool’. A) Adiponectin
secretion by ELISA. The graph shows the mean + SEM from
data collected in two independent experiments, with 3-4
biological replicates, each sample quantified in duplicate by
ELISA as described in the materials and methods section.
Statistical Analysis: One way ANOVA, * indicates statistical
significance at p<0.05. B) Western blot analysis of whole cell
lysates of HEK293 cells transfected with single or pair
combinations of FIP1 shRNA constructs or all FIP1 shRNA
constructs as a pool. Lysates were obtained HEK293
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expressing the shRNA empty vector (lane1), expressing single
FIP1 shRNA constructs or in pair combination (lanes 2 to 10) or
expressing all the shRNAs for FIP1 as a pool (lanes11 and 12).
Protein samples were separated on SDS-PAGE, transferred to
nitrocellulose filters and immunoblotted with specific antibodies
for FIP1and actin as loading control. The data shows a
representative blot of two independent experiments.
(TIF)
Figure S3.  Colocalization of endogenous adiponectin with
rab14 in 3T3L1 adipocytes. 3T3L1 control or cells expressing
shRNA for FIP1 were differentiated to adipocytes as indicated
in the methods section. Cells were fixed, permeabilized and
stained with an antibody against rab14 or adiponectin and
Alexa-488 and Alexa-594 conjugated antibodies.
Representative cells are shown of two independent
experiments. Determination of colocalization was carried out as
described in the methods section. Control (n = 6), FIP1 shRNA
(n = 4).
(TIF)
Figure S4.  Effects of hypoxia on FIP1 expression in 3T3L1
adipocytes. 3T3L1 cells were cultured and differentiated as
indicated in the methods section. Following differentiation a
subset of cells was placed into an hypoxia incubator
(hypoxystation) with 1% oxygen 5% CO2 and 94% nitrogen for
either 8h, 16h or 24 hours. Total RNA was isoladed and the
amount of mRNA for FIP1, adiponectin or Glut1 were
determined by real time PCR. Quantification was carried out
using the ∆∆Ct method using cyclophyllin A as internal control.
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